SK
Highly rated in
3
conditions

Dr. Steven C. Katz

Roger Williams Medical Center
Providence, RI
Highly rated in
3
conditions
Specialties:Surgical Oncology
Experience:23 Years
Accepts:Medicare
Highly rated in
3
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Steven C. Katz's experience treating your condition:
About Dr. Steven C. Katz

Steven Katz is a Surgical Oncologist in Providence, Rhode Island. Dr. Katz has been practicing medicine for over 23 years and is highly rated in 3 conditions, according to our data. His top areas of expertise are Melanoma, Liver Cancer, Merkel Cell Carcinoma, Pancreatic Cancer, and Liver Embolization.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Steven C. Katz it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
825 Chalkstone Ave, Providence, RI 02908
Other Locations
1180 Hope St, Bristol, RI 02809
Background & Education
Graduate Institution
New York University School Of Medicine, 2000
Specialties
Surgical Oncology
Licenses
Surgery in RI
Hospital Affiliations
Rhode Island Hospital
Charlton Memorial Hospital
Our Lady Of Fatima Hospital
Women & Infants Hospital
South County Hospital
Roger Williams Medical Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials
Phase 1b Study of the Efficacy and Safety of CAR2 Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases Resistant to Standard Therapy Using the HITM Method and Pressure Enabled Delivery Device
Enrollment Status: Terminated
Publish Date: January 17, 2023
Intervention Type: Biological
Study Drug: CAR2 Anti-CEA CAR-T Cells
Study Phase: Phase 1
Immunotherapy for Peritoneal Carcinomatosis (IPC) - A Phase I Study of the Safety and Efficacy of Anti-CEA CAR-T Cell Intraperitoneal Infusions for Treatment of CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites
Enrollment Status: Withdrawn
Publish Date: April 06, 2022
Intervention Type: Biological
Study Drug: Anti-CEA CAR-T cells
Study Phase: Phase 1
Phase Ib Trial of CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions Delivered With the Surefire Infusion System (SIS) for CEA-Expressing Liver Metastases or Pancreas Cancer
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Biological
Study Drug: Anti-CEA Chimeric Antigen Receptors-T Cells
Study Phase: Phase 1
Phase Ib Trial of CAR-T Hepatic Artery Infusions Followed by Selective Internal Radiation Therapy (SIRT) With Yttrium-90 Sir-Spheres® for CEA-Expressing Liver Metastases
Enrollment Status: Completed
Publish Date: March 26, 2019
Intervention Type: Biological, Device
Study Phase: Phase 1
Phase I Trial Of Intrahepatic Infusion Of 2nd Generation Designer T Cells For Cea-Expressing Liver Metastases
Enrollment Status: Completed
Publish Date: July 30, 2013
Intervention Type: Biological
Study Phase: Phase 1
View 4 Less Clinical Trials -
58 Total Publications
Novel treatment paradigms for metastatic uveal melanoma.
Journal: Cancer gene therapy
Published: September 10, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
CR
Dr. Chandrajit P. Raut
Surgical Oncology | General Surgery
Highly rated in
31
conditions
Surgical Oncology
General Surgery

Brigham Health

75 Francis Street Office - PBB-B-4 - Room 428

75 Francis Street, 
Boston, MA 
 38.5 mi

Chandrajit Raut is a Surgical Oncologist and a General Surgeon in Boston, Massachusetts. Dr. Raut has been practicing medicine for over 28 years and is highly rated in 31 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Gastrointestinal Stromal Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Raut is currently accepting new patients.

MS
Dr. Michelle C. Specht
Surgical Oncology | General Surgery
Highly rated in
19
conditions
Surgical Oncology
General Surgery

Mass General Brigham

Partners TeleStroke Center

15 Parkman St, 
Boston, MA 
 41.0 mi

Michelle Specht is a Surgical Oncologist and a General Surgeon in Boston, Massachusetts. Dr. Specht has been practicing medicine for over 27 years and is highly rated in 19 conditions, according to our data. Her top areas of expertise are Breast Cancer, Lymphatic Obstruction, Lymphedema, Inflammatory Breast Cancer, and Mastectomy. Dr. Specht is currently accepting new patients.

CF
Dr. Cristina R. Ferrone
Surgical Oncology | General Surgery
Highly rated in
18
conditions
Surgical Oncology
General Surgery

Mass General Brigham

MGH Waltham Cancer Center

52 2nd Ave, 
Waltham, MA 
 39.7 mi

Cristina Ferrone is a Surgical Oncologist and a General Surgeon in Waltham, Massachusetts. Dr. Ferrone has been practicing medicine for over 26 years and is highly rated in 18 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Gallbladder Removal, and Small Bowel Resection. Dr. Ferrone is currently accepting new patients.